These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6761569)

  • 1. Studies on the mechanism of action of cytosine arabinoside.
    Kufe DW; Major PP
    Med Pediatr Oncol; 1982; 10 Suppl 1():49-67. PubMed ID: 6761569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function.
    Kufe DW; Munroe D; Herrick D; Egan E; Spriggs D
    Mol Pharmacol; 1984 Jul; 26(1):128-34. PubMed ID: 6431261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical pharmacology of cytosine arabinoside.
    Momparler RL
    Med Pediatr Oncol; 1982; 10 Suppl 1():45-8. PubMed ID: 7162466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among Ara-CTP pools, formation of (Ara-C)DNA, and cytotoxicity of human leukemic cells.
    Kufe D; Spriggs D; Egan EM; Munroe D
    Blood; 1984 Jul; 64(1):54-8. PubMed ID: 6587917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and clinical pharmacology of low-dose ara-C.
    Kufe DW; Griffin JD; Spriggs DR
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):200-7. PubMed ID: 3925558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
    Kufe D; Herrick D; Crumpacker C; Schnipper L
    Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines.
    Zittoun J; Marquet J; David JC; Maniey D; Zittoun R
    Cancer Chemother Pharmacol; 1989; 24(4):251-5. PubMed ID: 2752506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ARA-C incorporation on deoxyribonucleic acid synthesis in cells.
    Major PP; Egan EM; Herrick DJ; Kufe DW
    Biochem Pharmacol; 1982 Sep; 31(18):2937-40. PubMed ID: 7138584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
    Ross DD; Chen SR; Cuddy DP
    Cancer Res; 1990 May; 50(9):2658-66. PubMed ID: 2328491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of resistance of leukemic cells to cytosine arabinoside from BrdUrd/DNA bivariate histograms.
    Lacombe F; Belloc F; Dumain P; Puntous M; Lopez F; Bernard P; Boisseau MR; Reiffers J
    Cytometry; 1992; 13(7):730-8. PubMed ID: 1451603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines.
    Noordhuis P; Kazemier KM; Kasperrs GJ; Peters GJ
    Leuk Res; 1996 Feb; 20(2):127-34. PubMed ID: 8628011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
    Hiddemann W; Kiehl M; Zühlsdorf M; Busemann C; Schleyer E; Wörmann B; Büchner T
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.
    Wang LM; White JC; Capizzi RL
    Cancer Chemother Pharmacol; 1990; 25(6):418-24. PubMed ID: 2311169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow.
    Tanaka M
    Leuk Res; 1993 Jul; 17(7):585-92. PubMed ID: 8326741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of cytotoxicity with incorporation of ara-C into DNA.
    Kufe DW; Major PP; Egan EM; Beardsley GP
    J Biol Chem; 1980 Oct; 255(19):8997-900. PubMed ID: 7410404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.
    Major PP; Egan EM; Beardsley GP; Minden MD; Kufe DW
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3235-9. PubMed ID: 6942429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simplified assay for measurement of cytosine arabinoside incorporation into DNA in Ara-C-sensitive and -resistant leukemic cells.
    Colly LP; Richel DJ; Arentsen-Honders W; Starrenburg IW; Edelbroek PM; Willemze R
    Cancer Chemother Pharmacol; 1990; 27(2):151-6. PubMed ID: 2249332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
    te Boekhorst PA; Löwenberg B; Sonneveld P
    Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of leukemic cell DNA strand breaks with adriamycin and cytosine arabinoside.
    Fram RJ; Egan EM; Kufe DW
    Leuk Res; 1983; 7(2):243-9. PubMed ID: 6855268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia.
    Avramis VI; Mecum RA; Nyce J; Steele DA; Holcenberg JS
    Cancer Chemother Pharmacol; 1989; 24(4):203-10. PubMed ID: 2473850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.